William Blair Senior Biotech Analyst Andy Hsieh shares an overview of the obesity space heading into 2026
Dec 30, 2025
33:28
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
He discusses the recently approved Wegovy pill, and compares and contrasts it to other oral programs from Lilly, Structure, and Corbus. Plus, how is the amylin space looking compared to GLP-1s, and a preview of Viking's 2026.
BiotechTV - News